Results 131 to 140 of about 25,104 (242)

Dark Heritage Prospection ‐ Mapping the Treblinka II Extermination Camp Using a Magnetometer Survey and Integrated Archival Sources

Archaeological Prospection, EarlyView.
ABSTRACT The history of Nazi German extermination camps has, until recently, relied primarily on eyewitness testimony. Very few official documents detailing the facilities survived the war due to the special operation ‘Sonderaktion 1005’, dedicated to hiding their existence and extent.
Sebastian Różycki, Michał Pisz, Paweł Bylina, James Walker, Lucy Benoit   +4 more
wiley   +1 more source

Endoscopic Calcaneoplasty Achieves Excellent Functional Outcomes in Haglund's Deformity

Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To evaluate the functional outcomes of endoscopic calcaneoplasty for patients with Haglund's deformity who are recalcitrant to conservative management and to assess complication rates and the proportion of patients achieving minimal clinically important difference in functional outcome scores.
Samuel Sing Li Ong, Raj Kumar Socklingam, Ing How Moo, Charles Kam King Kon   +3 more
wiley   +1 more source

Multidimensional and Multidisciplinary Management of Heart Failure Patients with Frailty. [PDF]

Card Fail Rev
Vitale C, Fragasso G, Uchmanowicz I, Sciacqua A, Díez-Villanueva P, Sze S, Denfeld QE, Anker MS, Marques-Sule E, Strömberg A, Berthelot E, von Haehling S, Rosano G, Doehner W, Zhang Y, Hage C.   +15 more
europepmc   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

Association of Fried Frailty Phenotype With Occlusal Status, Health-Related Quality of Life, and Nutritional Status Among Older Adults Living in Long-Term Care. [PDF]

J Oral Rehabil
Zórawna M, Mäntylä P, Saarela RKT, Pitkälä KH, Kautiainen H, Jyväkorpi SK, Hiltunen K.   +6 more
europepmc   +1 more source

Cardiovascular and neuropsychiatric outcomes with PCSK9 inhibitors in atherosclerotic cardiovascular disease: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Study design and main findings. After 1:1 propensity score matching, 60 885 PCSK9 inhibitor users and 60 885 statin‐only users with ASCVD were compared. Kaplan–Meier curves show 12‐month cumulative event‐free survival for MACE, psychiatric disease, and neurodegenerative disease.
Tianshu Gu, Yang Chen, Nan Zhang, Uazman Alam, Riccardo Proietti, Tong Liu, Kang‐Yin Chen, Gregory Y. H. Lip   +7 more
wiley   +1 more source

The Association of an Electronic Frailty Index with Glaucoma Shunt Outcomes. [PDF]

Geriatrics (Basel)
Edupuganti N, Saxena R, Thompson AC.
europepmc   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Best Evidence Summary for the Management of Frailty in Elderly Patients in Emergency Department-Integrative Review. [PDF]

Nurs Open
Yuan M, Yang H, Dai Y, Sun X, Zhang Y, Liu X.   +5 more
europepmc   +1 more source

Long‐term cost‐effectiveness of belatacept vs. tacrolimus in kidney transplantation: Trade‐off between metabolic benefit and immunological risk

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the long‐term cost‐effectiveness of belatacept vs. tacrolimus as maintenance immunosuppression in adult kidney transplant recipients, focusing on the trade‐off between reduced new‐onset diabetes after transplantation (NODAT), immunological risk and potential renal benefit.
Salvatore Di Maria, Carmelo Puglia, Alessio Provenzani   +2 more
wiley   +1 more source